NOT-DA-23-040: Notice of Change to section for PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"

Notice of Change to section for PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"

Notice Number:

NOT-DA-23-040

Key Dates

Release Date:

October 12, 2023

Related Announcements

June 14, 2023 - Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed). See NOFO PAR-23-194.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to clarify that letters of intent are not required for PAR-23-194 (NIDA R36 Substance Use/Substance Use Disorder Dissertation Research Award).

The following section of PAR-23-194 is updated as follows, shown in bold italics.

Part 1. Overview Information

Key Dates

Currently reads:

Letter of Intent Due Date(s)

30 days prior to the application due date

Revised to read:

Letter of Intent Due Date(s)

Not Required

All other aspects of this PAR remain the same.

Inquiries

Please direct all inquiries to:

Lindsey Friend, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-402-1428
Email: lindsey.friend@nih.gov